Login / Signup

Transfection of glycoprotein encoding mRNA for swift evaluation of N-glycan engineering strategies.

Nina BydlinskiMichael T CoatsDaniel MareschRichard StrasserNicole Borth
Published in: Biotechnology progress (2020)
N-glycosylation is defined as a key quality attribute for the majority of complex biological therapeutics. Despite many N-glycan engineering efforts, the demand to generate desired N-glycan profiles that may vary for different proteins in a reproducible manner is still difficult to fulfill in many cases. Stable production of homogenous structures with a more demanding level of processing, for instance high degrees of branching and terminal sialylation, is particularly challenging. Among many other influential factors, the level of productivity can steer N-glycosylation towards less mature N-glycan structures. Recently, we introduced an mRNA transfection system capable of elucidating bottlenecks in the secretory pathway by stepwise increase of intracellular model protein mRNA load. Here, this system was applied to evaluate engineering strategies for enhanced N-glycan processing. The tool proves to indeed be valuable for a quick assessment of engineering approaches on the cellular N-glycosylation capacity at high productivity. The gene editing approaches tested include overexpression of key Golgi-resident glycosyltransferases, partially coupled with multiple gene deletions. Changes in galactosylation, sialylation, and branching potential as well as N-acetyllactosamine formation were evaluated.
Keyphrases
  • cell surface
  • binding protein
  • quality improvement
  • climate change
  • high resolution
  • copy number
  • genome wide
  • patient safety
  • dna methylation
  • risk assessment
  • protein protein
  • mass spectrometry
  • endoplasmic reticulum